Exactly @bungy234. Also I think that each of us should be just concerned with our own individual investment here & your reasons for investing & trading strategy. They will all be different, some opinions appear to be very shallow, not looking at the bigger picture here.
Whether that is misunderstood or a deliberate misrepresentation, I don’t know, it appears to change day by day, when the FA remains stable.
I hope that recent Investor interview cleared up a few questions, because ACW have the funding & capability to run trials independently if so needed. $8 million in the bank by the end of year & spend winding down at completion of current trials...ready for the next round in AD & other indications. There was no mention of share consolidation.
With data from Xanadu (large international trial) Xanahes cohort 1 @20mg, Target Occupancy & Toxicology studies, there is a huge amount of data in humans here, with proof of cognitive improvement & also crossing the BBB & inhibiting cortisol (Xanadu Trial also). So really, if we are running the next barrage of trials without some form of milestone arrangement with Big Pharma, I will be very surprised, but Actinogen is a well run company that will keep the best interest of drug development, IP & SHs also in mind. I am looking forward to all of this new data on Xanamem & in AD in particular.
One thing mentioned in the recent Investor interview was ACW top 10, they are all still there, including BVF. I think their analysts will have a bit more grey matter onboard than some posters here, with their large investments being accountable.
It’s really nice to see interviewers also get it & say WOW! A lot of Aussie Biotechs fly under the radar until clinical trials get noticed & then, BOOM it happens...out of the Blue (but not really, years in development). GLTAH
- Forums
- ASX - By Stock
- ACW
- @US10 silence since XanaHES announcement
@US10 silence since XanaHES announcement, page-22
-
-
- There are more pages in this discussion • 189 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACW (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.2¢ |
Change
0.016(34.8%) |
Mkt cap ! $166.3M |
Open | High | Low | Value | Volume |
4.5¢ | 6.2¢ | 4.4¢ | $1.491M | 28.50M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 6.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.3¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.062 |
3 | 168666 | 0.061 |
1 | 540371 | 0.060 |
3 | 91321 | 0.059 |
3 | 140000 | 0.058 |
Price($) | Vol. | No. |
---|---|---|
0.063 | 100000 | 1 |
0.064 | 135640 | 4 |
0.065 | 112475 | 2 |
0.067 | 6000 | 1 |
0.069 | 206000 | 1 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online